Frequently Asked Questions
19 questions across 4 topics
Common questions about lipid peroxidation, deuterium, D-PUFAs, and the science behind the book.
About the Book
1 question
Why are there penguins in the corner of every page in the book?
If you flip through the page corners from back to front, you'll see a flip-book-style cartoon illustrating the chain reaction of lipid peroxidation, with grey penguins representing D-PUFAs. Additional guidance on page 69 and page 265. This animation only works in the printed edition.
The Science of LPO
7 questions
What is an isotope?
An isotope is a variant of a chemical element with the same number of protons but a different number of neutrons. Deuterium, for example, is a stable isotope of hydrogen: it has one proton and one neutron instead of just a proton. This subtle difference makes deuterium-carbon bonds harder to break, which is why D-PUFAs resist lipid peroxidation.
What is peroxidation?
Peroxidation is the oxidation of lipids (fatty molecules) by reactive oxygen species, producing peroxides and other harmful by-products. In biology, lipid peroxidation is the most consequential form—it damages cell membranes and drives aging and age-related diseases.
How do chemical isotopes work?
Chemical isotopes have the same number of protons (and thus the same chemical identity) but different masses due to different numbers of neutrons. Heavier isotopes form slightly stronger bonds that are harder to break. Deuterium, the heavy isotope of hydrogen, slows down reactions that involve breaking C-H bonds—including the chain reaction of lipid peroxidation in cell membranes.
Is lipid peroxidation the driver of aging?
Aging is multifaceted and to slow it down will require a coordinated use of various interventions. That said, LPO stands out as a major contributor, largely due to the utter importance of lipid membranes to biology. 30% of all biochemical reactions happen in membranes. Neurons, mitochondria, the visual apparatus and many other things rely on membrane integrity for their function. And all that can be compromised, or destroyed, by LPO, pushing aging forward.
Is lipid peroxidation the driver of neurological diseases?
It increasingly looks so. Consider traumatic brain injury: the initial concussion produces a burst of lipid peroxidation, can years later yield Parkinson's, Alzheimer's, various dementias, ALS, MS or other ailments, indeed implicating LPO as a unifying mechanism behind these conditions.
What is so bad about LPO?
People usually think about reduced membrane fluidity and impaired barrier function. This, however, pales in comparison with the downstream consequences. Oxidised fatty acids fragment into smaller pieces, which are often highly reactive. These can wreak havoc by reacting with one, or several, biomolecules, leading to accumulation of large insoluble waste deposits.
Are transition metals good or bad?
Both. Transition metals are genuinely Janus-faced. Enzymes need small amounts of them as essential cofactors, yet the very properties that make them useful inside enzymes make them hazardous when they're free in the cell. In particular, transition metals can generate reactive oxygen species (ROS), which in turn can trigger the radical chain reaction of lipid peroxidation.
D-PUFAs: Safety & Mechanism
8 questions
How do D-PUFAs compare to antioxidants?
They are incomparable. Antioxidants are tightly controlled and their levels in membranes cannot exceed certain fixed values, at best. At worst, they can do an about-face, turning into pro-oxidants. As smokers on antioxidants learned, at their peril, in a human clinical trial.
Are D-PUFAs antioxidants?
No. Suppose you have a wooden (= PUFA) fence. You'll need to keep stomping out (= antioxidant) fires (= ROS) approaching it to preserve it. Now suppose the fence is the same shape and size, but made of concrete… Antioxidants are used up stopping the fire, while D-PUFAs are just impervious.
Is deuterium radioactive?
No. Deuterium is a stable isotope of hydrogen.
Is deuterium toxic?
No. Our bodies are well adapted to its natural presence (150 ppm, or 0.015% in sea water). Roughly, every 6500th atom of hydrogen is deuterium, giving 33 g deuterium per cubic metre of sea water. A typical human body contains about 1.5 g of deuterium, distributed across body water and organic molecules.
Why is deuterium expensive?
Given its low abundance, it takes a lot of effort to separate (concentrate) heavy water from fresh water. While various methods exist, they are all energy-hungry.
The value of kinetic isotope effect for deuterium in most reactions is typically 2 to 6. Why is the KIE larger for the chain reaction of lipid peroxidation as compared to stoichiometric reactions?
Affecting the chain at every step, the kinetic isotope effect "accumulates" along the entire chain, producing values far higher than those seen in the single-step reactions.
Are D-PUFAs drugs or supplements?
In a sense, they are both - and neither. Conventional drugs are foreign to the body, whereas both PUFAs and D-PUFAs are natural building blocks of cell membranes. Hydrogen and deuterium are simply isotopes of the same element, and deuterium is already present in cells. PUFAs and their D-PUFA counterparts behave identically in most chemical contexts, except in the LPO chain reaction. Pharmacotaxonomy is definitely lagging behind here. Perhaps a new, hybrid term should be used. Please share your ideas.
Will taking D-PUFAs orally ensure their delivery to the right places in the body?
Yes. D-PUFAs travel through the body exactly as normal PUFAs do. As essential nutrients, PUFAs (and D-PUFAs) are absorbed in the small intestine, repackaged by liver and carried through the bloodstream to tissues throughout the body, first and foremost to those that need them most.
Inflammation & Health
3 questions
How will D-PUFAs affect inflammation?
Through multiple interconnected mechanisms. Oxidized lipids are inherently pro-inflammatory, for example in the atherosclerosis setting. Some end-products of LPO, such as isoprostanes, mimic the structure of pro-inflammatory prostaglandins, so keeping them at low levels is beneficial. Other LPO end-products can irreversibly glue various biomolecules together, generating persistent inflammatory background. Lipoxygenases and cyclooxygenases convert arachidonic acid into a smorgasbord of predominantly pro-inflammatory eicosanoids. With age, these processes pile up, collectively contributing to "inflammaging". This pro-inflammatory "noise" can be mitigated by D-PUFAs.
Are D-PUFAs similar to NSAIDs like aspirin?
No. Aspirin covalently reacts with COX enzymes, irreversibly "killing" them. Inhibitors of COX and LOS are enzyme-specific, and as a result often skew the important fine balance of various eicosanoids, such as in aspirin-sensitive asthma. D-PUFAs act across the board, softly down-regulating all COX and LOX enzymes. This dials down without distorting the delicate ratios.
Do studies in animal disease models corroborate the benefits of D-PUFAs?
Yes. Multiple animal studies demonstrate that D‑PUFAs can mitigate pathology across a range of disease models. It's important to remember, however, that no animal model fully predicts human disease. As Richard Klausner noted in 1998, "We have cured mice of cancer for decades—and it simply didn't work in humans."
Even so, the collective evidence from these models supports the idea that lipid peroxidation plays a central role in disease initiation and progression. Across neurological, retinal, mitochondrial, and other age‑related conditions, D‑PUFAs consistently prevent or markedly slow pathological changes. For example, several independent studies using distinct Parkinson's disease models—in cells, mice, and rats—found that D‑PUFAs robustly reduced disease‑related damage.
Even so, the collective evidence from these models supports the idea that lipid peroxidation plays a central role in disease initiation and progression. Across neurological, retinal, mitochondrial, and other age‑related conditions, D‑PUFAs consistently prevent or markedly slow pathological changes. For example, several independent studies using distinct Parkinson's disease models—in cells, mice, and rats—found that D‑PUFAs robustly reduced disease‑related damage.
Have another question?
We are happy to answer questions about the book, the science, or D-PUFAs.
Want the full picture?
This article covers just one piece of the puzzle. The book connects all the dots: from the chemistry of aging to the deuterium approach.